Lung-RADS v2022

Lung Cancer Screening CT assessment and management

1 Scan Information
2 Nodule Characteristics
Nodule Type
Average of long and short axis
Nodules with benign calcification patterns are classified as Category 2 regardless of size.
3 Suspicious Features (4X Modifier)

About Lung-RADS v2022

Lung-RADS (Lung Imaging Reporting and Data System) is a quality assurance tool developed by the American College of Radiology (ACR) to standardize lung cancer screening CT reporting and management recommendations.

Screening Eligibility (USPSTF 2021)

  • Age 50-80 years
  • ≥20 pack-year smoking history
  • Current smoker OR quit within past 15 years
  • No symptoms of lung cancer

Lung-RADS Categories

Category Description Malignancy Risk Management
1 Negative (no nodules) <1% Continue annual LDCT
2 Benign appearance/behavior <1% Continue annual LDCT
3 Probably benign 1-2% 6-month LDCT
4A Suspicious 5-15% 3-month LDCT
4B Very suspicious >15% Chest CT, PET-CT, tissue sampling
4X Suspicious + additional features Variable As per 4A/4B + clinical correlation

Size Thresholds - Solid Nodules

Baseline Screening

Size Category
<6 mm2
6-8 mm3
8-15 mm4A
≥15 mm4B

New Nodule on Follow-up

Size Category
<4 mm2
4-6 mm3
6-8 mm4A
≥8 mm4B

Size Thresholds - Part-Solid Nodules

Total Size Solid Component Category
<6 mmAny2
≥6 mm<6 mm3
≥6 mm6-8 mm4A
≥6 mm≥8 mm4B

Size Thresholds - Ground-Glass Nodules

Scan Type Category 2 Category 3
Baseline<30 mm≥30 mm
New nodule<20 mm≥20 mm

4X Modifier

The "X" modifier is added to category 3, 4A, or 4B when additional suspicious features are present:

  • Spiculation: Irregular margins with radiating linear strands
  • Lymphadenopathy: Enlarged or morphologically suspicious nodes
  • Growing nodule: Increase in size compared to prior imaging
  • Known malignancy: History of primary cancer (risk of metastasis)
  • Part-solid with growing solid component

Benign Calcification Patterns

Nodules with the following calcification patterns are classified as Category 2 regardless of size:

  • Complete (diffuse) calcification
  • Central calcification
  • Laminated (concentric) calcification
  • Popcorn calcification (hamartoma)
  • Fat-containing nodule (hamartoma)

Key Changes in Lung-RADS v2022

  • Adjusted size thresholds based on nodule volume
  • Clarified management for atypical adenomatous hyperplasia-like GGNs
  • Enhanced guidance for part-solid nodule assessment
  • Updated S modifier for incidental findings

References

  1. American College of Radiology. Lung-RADS v2022 Assessment Categories. ACR; 2022. ACR Lung-RADS
  2. Kazerooni EA, Armstrong MR, Amorosa JK, et al. ACR CT Accreditation Program and the Lung Cancer Screening Program Designation. J Am Coll Radiol. 2015;12(1):38-42. doi:10.1016/j.jacr.2014.08.016
  3. McKee BJ, Regis SM, McKee AB, et al. Performance of ACR Lung-RADS in a Clinical CT Lung Screening Program. J Am Coll Radiol. 2016;13(2):R25-R29. doi:10.1016/j.jacr.2015.09.035
  4. Pinsky PF, Gierada DS, Black W, et al. Performance of Lung-RADS in the National Lung Screening Trial. Ann Intern Med. 2015;162(7):485-491. doi:10.7326/M14-2086
  5. US Preventive Services Task Force. Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2021;325(10):962-970. doi:10.1001/jama.2021.1117